Clinical Trial Update: R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse [Phase 2]

View source ↗

Summary

Phase 2 trial from Fudan University evaluating R-CDOP with intrathecal methotrexate for diffuse large B-cell lymphoma patients at high risk of CNS relapse; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• PREDNISONE (Prednisone)
• R-CDOP
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: RECRUITING